Search Results
You are looking at 1 - 3 of 3 items for
- Author: Michio Otsuki x
- Refine by access: All content x
Search for other papers by Tomoaki Hayakawa in
Google Scholar
PubMed
Department of Adipose Management, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Search for other papers by Atsunori Fukuhara in
Google Scholar
PubMed
Search for other papers by Aya Saiki in
Google Scholar
PubMed
Search for other papers by Michio Otsuki in
Google Scholar
PubMed
Search for other papers by Iichiro Shimomura in
Google Scholar
PubMed
Primary aldosteronism (PA) is caused by autonomous overproduction of aldosterone, which induces organ damage directly via activation of the mineralocorticoid receptor (MR); however, no specific or sensitive biomarkers are able to reflect MR activity. Recently, it is found that urinary extracellular vesicles (uEVs) are secreted by multiple cell types in the kidney and are an enriched source of kidney-specific proteins. Here, we evaluate sodium transporters in uEVs as candidates of biomarkers of MR activity in the clinical setting. Sixteen patients were examined to determine their plasma aldosterone concentration (PAC) and renin activity, and their morning urine was collected. The protein levels of two sodium transporters in uEVs, γ-epithelial sodium channel (γENaC) and thiazide-sensitive sodium chloride cotransporter (NCC), were quantified by Western blot analysis, and their clinical correlation with PAC was determined. Consequently, we found PAC was significantly correlated with the γENaC protein level adjusted by the CD9 protein level in uEVs (correlation coefficient = 0.71). PAC was also correlated with the NCC protein level adjusted by the CD9 protein level in uEVs (correlation coefficient = 0.61). In two PA patients, treatment with an MR antagonist or adrenalectomy reduced γENaC/CD9 in uEVs. In conclusion, γENaC/CD9 in uEVs is a valuable biomarker of MR activity in PA patients and may be a useful biomarker for other MR-associated diseases.
Search for other papers by Lovisa Lundholm in
Google Scholar
PubMed
Search for other papers by Milica Putnik in
Google Scholar
PubMed
Search for other papers by Michio Otsuki in
Google Scholar
PubMed
Search for other papers by Sandra Andersson in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Jan-Åke Gustafsson in
Google Scholar
PubMed
Search for other papers by Karin Dahlman-Wright in
Google Scholar
PubMed
Obesity has become a major health problem in many parts of the world. Estrogens are known to reduce adipose tissue mass in both humans and animals but the molecular mechanisms are not well characterized. We used gene expression profiling to study long-term effects of estrogen on gene expression in mouse white adipose tissue and hypothalamus. Overall, the effects of estrogen on hypothalamic gene expression were much smaller than the corresponding effects on white adipose tissue gene expression. We characterize in detail estrogenic regulation of glutathione peroxidase 3 (GPX3). Our studies suggest that GPX3 is a direct estrogen receptor α target gene in white adipose tissue. Since obesity is correlated with oxidative stress, and GPX3 has been demonstrated to be lower in obesity and higher after weight loss, we hypothesize that GPX3 is one important mediator of effects of estrogen in relation to fat mass. Additional genes that were affected by estrogen in adipose tissue include cell death-inducing DNA fragmentation factor, α-subunit-like effector A (CIDEA), a gene shown to be related to body fat in mice. We conclude that estrogen has large effects on gene expression in white adipose tissue and hypothesize that GPX3 and CIDEA could be important mediators of the effects of estrogen on fat mass.
Search for other papers by Tomoaki Hayakawa in
Google Scholar
PubMed
Search for other papers by Tomomi Minemura in
Google Scholar
PubMed
Search for other papers by Toshiharu Onodera in
Google Scholar
PubMed
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
Search for other papers by Jihoon Shin in
Google Scholar
PubMed
Search for other papers by Yosuke Okuno in
Google Scholar
PubMed
Department of Adipose Management, Osaka University Graduate School of Medicine, Osaka, Japan
Search for other papers by Atsunori Fukuhara in
Google Scholar
PubMed
Search for other papers by Michio Otsuki in
Google Scholar
PubMed
Search for other papers by Iichiro Shimomura in
Google Scholar
PubMed
Active glucocorticoid levels are elevated in the adipose tissue of obesity due to the enzyme 11 beta-hydroxysteroid dehydrogenase type 1. Glucocorticoids can bind and activate both glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), and pharmacological blockades of MR prevent high-fat diet-induced obesity and glucose intolerance. To determine the significance of MR in adipocytes, we generated adipocyte-specific MR-knockout mice (AdipoMR-KO) and fed them high-fat/high-sucrose diet. We found that adipocyte-specific deletion of MR did not affect the body weight, fat weight, glucose tolerance or insulin sensitivity. While liver weight was slightly reduced in AdipoMR-KO, there were no significant differences in the mRNA expression levels of genes associated with lipogenesis, lipolysis, adipocytokines and oxidative stress in adipose tissues between the control and AdipoMR-KO mice. The results indicated that MR in mature adipocytes plays a minor role in the regulation of insulin resistance and inflammation in high-fat/high-sucrose diet-induced obese mice.
